Cargando…
A Novel Dimeric Inhibitor Targeting Beta2GPI in Beta2GPI/Antibody Complexes Implicated in Antiphospholipid Syndrome
BACKGROUND: β2GPI is a major antigen for autoantibodies associated with antiphospholipid syndrome (APS), an autoimmune disease characterized by thrombosis and recurrent pregnancy loss. Only the dimeric form of β2GPI generated by anti-β2GPI antibodies is pathologically important, in contrast to monom...
Autores principales: | Kolyada, Alexey, Lee, Chang-Jin, De Biasio, Alfredo, Beglova, Natalia |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002267/ https://www.ncbi.nlm.nih.gov/pubmed/21179511 http://dx.doi.org/10.1371/journal.pone.0015345 |
Ejemplares similares
-
Oxidation of beta(2)-glycoprotein I (beta(2)GPI) by the hydroxyl radical alters phospholipid binding and modulates recognition by anti-beta(2)GPI autoantibodies
por: Arvieux, J, et al.
Publicado: (2001) -
Dimerized Domain V of Beta2-Glycoprotein I Is Sufficient to Upregulate Procoagulant Activity in PMA-Treated U937 Monocytes and Require Intact Residues in Two Phospholipid-Binding Loops
por: Kolyada, Alexey, et al.
Publicado: (2017) -
Hydroxychloroquine partially prevents endothelial dysfunction induced by anti-beta-2-GPI antibodies in an in vivo mouse model of antiphospholipid syndrome
por: Urbanski, Geoffrey, et al.
Publicado: (2018) -
PredGPI: a GPI-anchor predictor
por: Pierleoni, Andrea, et al.
Publicado: (2008) -
GPI-anchor and GPI-anchored protein expression in PMM2-CDG patients
por: de la Morena-Barrio, Maria E, et al.
Publicado: (2013)